Division of Translational Cancer Research
391 – 400 of 599
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL)
(
- Contribution to journal › Article
-
Mark
No reason to reconsider HIF-2 as an oncogene in neuroblastoma and other cancer forms
2017) In Proceedings of the National Academy of Sciences of the United States of America 114(51). p.10856-10858(
- Contribution to journal › Letter
-
Mark
Abstract P1-07-17: The SCAN-B study: 5-year summary of a large-scale population-based prospective breast cancer translational genomics platform covering a wide geography of Sweden (NCT02306096)
(
- Contribution to journal › Published meeting abstract
-
Mark
Tyrosine 842 in the activation loop is required for full transformation by the oncogenic mutant FLT3-ITD
(
- Contribution to journal › Article
-
Mark
Early Cambrian oxygen minimum zone-like conditions at Chengjiang
(
- Contribution to journal › Article
-
Mark
Cell-Type-Specific Gene Programs of the Normal Human Nephron Define Kidney Cancer Subtypes
(
- Contribution to journal › Article
-
Mark
Hypoxia and Cancer Stem Cell Regulation
2017) p.101-126(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Efficacy of the CDK inhibitor dinaciclib in vitro and in vivo in T-cell acute lymphoblastic leukemia
(
- Contribution to journal › Article
-
Mark
HIF-dependent Signaling Pathways in Cancer
2017)(
- Thesis › Doctoral thesis (compilation)
-
Mark
CD44 interacts with HIF-2α to modulate the hypoxic phenotype of perinecrotic and perivascular glioma cells
(
- Contribution to journal › Article